PATENT CLAIM ANALYSIS

Application Number: 16119027
Application Type: Utility
Filing Date: 2018-08
Publication Date: 2019-03
Patent Classification: ["424", "400000"]

Abstract:
Provided are methods relating to compositions that include a CDP-camptothecin or camptothecin derivative conjugate, e.g., CRLX101.

Claim (Index 12):
The method of  claim 1 , wherein the method further comprises administering an agent which ameliorates a side effect associated with the treatment, and optionally wherein: (i) the agent is administered in an amount sufficient to ameliorate bladder toxicity associated with treatment; (ii) the agent is selected from the group consisting of saline, D5 half normal saline and D5 water; (iii) the agent is administered prior to, during or after administration of the CDP-camptothecin conjugate, particle or composition; (iv) the agent is administered prior to administration of the CDP-camptothecin conjugate, particle or composition; (v) the agent is administered prior to and after administration of the CDP-camptothecin conjugate, particle or composition; (vi) the agent ameliorates a side effect associated with radiation treatment; or (vii) the agent is a radiation protector.

Metadata:
- Claim Count in Document: 35.0
- Percentile: 96.0
- Lexical Diversity: 1.05556
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['15312139', '14885174', '14955469', '15069208', '15723981']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7213202201193349
- 35 USC 102 Novelty (BERT): 0.5024226987620108
- Combined Prediction Score: 0.6994304679836025
- Mean Citation Score: 200.970564
- Max Citation Score: 204.61128
- Similarity Product: 122.75699186061856

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test